[1]
Mostafi, M., Jabin, M., Chowdhury, Z., Khondoker, M., Ali, S., Tamanna, R., Rezwan, R. and Alomgir, S. 2020. The outcome of Daclatasvir and low dose Sofosbuvir therapy in end-stage renal disease patients with hepatitis C virus infection. Ukrainian Journal of Nephrology and Dialysis. 2(66) (Apr. 2020), 3-8. DOI:https://doi.org/10.31450/ukrjnd.2(66).2020.01.